Tissue repair

Information

  • Patent Grant
  • 11857176
  • Patent Number
    11,857,176
  • Date Filed
    Wednesday, June 22, 2022
    a year ago
  • Date Issued
    Tuesday, January 2, 2024
    4 months ago
Abstract
An apparatus includes a flexible fixation member having a body with a longitudinal extent and a width, the body defining a plurality of openings through the body, each of the plurality of openings formed substantially cross wise through the width of the body, and a suture having two terminal ends, the suture being interwoven through each of the plurality of openings in the body of the fixation member such that multiple portions of the fixation member are slidably coupled to the suture and configurable to form a cluster within a surgical site.
Description
TECHNICAL FIELD

This disclosure relates to apparatus and methods for repairing tissue, and more particularly, to apparatus and methods for coupling soft tissue to bone.


BACKGROUND

Arthroscopic procedures using sutures and suture anchors have been used in tissue repair to, for example, secure soft tissue to bone. Suture anchors, such as metallic or other absorbable or non-absorbable polymer materials, tend to displace a certain volume of bone to provide adequate fixation strength. The larger a necessary repair may require multiple anchors to properly reattach torn soft tissue to bone. The size of many of these anchors can limit the number and location of fixation points as well as affect the anatomic nature of some tissue repairs. Small anchors typically do not provide sufficient holding strength to be effective in some tissue repair procedures or certain bone areas


SUMMARY

In one general aspect, an apparatus comprises a flexible fixation member comprising a body with a longitudinal extent and a width, the body defining a plurality of openings through the body, each of the plurality of openings formed substantially cross wise through the width of the body, and a suture comprising two terminal ends, the suture being interwoven through each of the plurality of openings in the body of the fixation member such that multiple portions of the fixation member are slidably coupled to the suture and configurable to form a cluster within a surgical site.


Implementations may include one or more of the following features. For example, the flexible fixation member comprises one of a suture, tape, braid, or mesh. The flexible fixation member is non-tubular. The flexible fixation member and the suture comprise a size 2 suture. The apparatus further comprises a delivery device comprising a cannula configured to receive the flexible fixation member therein. The delivery device further comprises an elongated member configured to slide within the cannula from a retracted position to an advanced position and configured to eject the flexible fixation member from the cannula when the elongated member is in the advanced position. The portions of the fixation member are configured to slide relative to the suture to form a cluster comprising a group of folds within a surgical site. The suture is interwoven through the plurality of openings in the fixation member to form two substantially parallel tail sections of suture. The fixation member comprises at least one curved portion that comprises, in series along the curved portion, a first opening receiving a portion of one of the two parallel tail sections, a second and third opening receiving portions of the other of the two parallel tail sections, and a fourth opening receiving another portion of the one of the two parallel tail sections. The fixation member and the suture are formed from a material that is absorbable within a body of a patient. The fixation member comprises a biologic growth material. In addition, the apparatus further comprises a second suture having two terminal ends, the second suture being interwoven through each of the plurality of openings in the body of the fixation member such that portions of the fixation member are slidably coupled to the suture.


In another general aspect, an assembly comprises a non-tubular tissue anchor formed from one of a suture, mesh, braid, or tape, the tissue anchor comprising a body with a longitudinal extent and a width, the body defining a plurality of openings along the longitudinal extent of the body and through the width of the body, a suture interwoven through each of the plurality of openings in the body of the tissue anchor such that portions of the tissue anchor are slidable relative to the suture and configurable to form a cluster within a surgical site, and a delivery device comprising a cannula configured to receive the flexible fixation member therein.


Implementations may include one or more of the following features. For example, the delivery device further comprises an elongated member configured to slide within the cannula from a retracted position to an advanced position and configured to eject the flexible fixation member from the cannula when the elongated member is in the advanced position. The tissue anchor and the suture comprise a size 2 suture. The portions of the tissue anchor are configured to slide relative to the suture to form a cluster comprising a group of folds within a surgical site. The suture is interwoven through each of the plurality of openings in the tissue anchor to form two substantially parallel tail sections of suture. The tissue anchor and the suture are formed from a material that is absorbable within a body of a patient. The tissue anchor comprises a biologic growth material.


In another general aspect, an apparatus comprises a tissue anchor comprising a plurality of connected knots, and a suture comprising two terminal ends, the suture passing through one or more of the plurality of connected knots such that the tissue anchor is slidably coupled to the suture.


Implementations may include one or more of the following features. For example, the plurality of connected knots comprise, in sequence, a first square knot, two free alternating post half hitch knots, a second square knot, two free alternating post half hitch knots, and a third square knot. The suture passes through each of the first, second, and third square knots. The apparatus further comprises a second suture having two terminal ends, the second suture passing through one or more of the plurality of connected knots such that the tissue anchor is slidably coupled to the second suture. The tissue anchor and the suture are formed from a material that is absorbable within a body of a patient. The tissue anchor comprises a biologic growth material. The apparatus further comprises a delivery device comprising a cannula configured to receive the tissue anchor therein. The delivery device further comprises an elongated member configured to slide within the cannula from a retracted position to an advanced position and configured to eject the tissue anchor from the cannula when the elongated member is in the advanced position.


In another general aspect, a wound closure assembly comprises a tissue anchor comprising a plurality of connected knots, and a suture comprising two terminal ends, the suture passing through one or more of the plurality of connected knots such that the tissue anchor is slidably coupled to the suture, and a delivery device comprising a cannula configured to receive the tissue anchor therein.


Implementations may include one or more of the following features. For example, the delivery device further comprises an elongated member configured to slide within the cannula from a retracted position to an advanced position and configured to eject the tissue anchor from the cannula when the elongated member is in the advanced position.


In another general aspect, a method of closing a tissue wound comprises delivering a wound closure device to a surgical site, the wound closure device comprising a flexible fixation member having a body with a longitudinal extent and a width, the body defining a plurality of openings through the body, each of the plurality of openings formed substantially cross wise through the width of the body, and a suture having two terminal ends, the suture being interwoven through each of the plurality of openings in the body of the fixation member such that multiple portions of the fixation member are slidably coupled to the suture and configurable to form a cluster within a surgical site, removing the flexible fixation member from the wound closure device at the surgical site, and pulling on the terminal ends of the suture to form a cluster of the multiple portions of the fixation member at the surgical site.


Implementations may include one or more of the following features. For example, the method further comprises drilling a hole into the tissue. The removing step comprises ejecting the flexible fixation member from the device into the hole. The hole passes completely through the tissue and the delivering step comprises delivering the device through the hole and the removing step comprises placing the flexible fixation member on an opposite side of the hole. The method further comprises maintaining the wound closure device in position at the surgical site as the terminal ends of the suture are pulled to form the cluster of the multiple portions of the fixation member at the surgical site.


In another general aspect, a method of closing a tissue wound, comprises delivering a wound closure device to a surgical site, the wound closure device comprising a tissue anchor having a plurality of connected knots, and a suture having two terminal ends, the suture passing through one or more of the plurality of connected knots such that the tissue anchor is slidably coupled to the suture, removing the tissue anchor from the wound closure device at the surgical site, and pulling on the terminal ends of the suture to form a cluster of the plurality of connected knots at the surgical site.


Implementations may include one or more of the following features. For example, the method further comprises drilling a hole into the tissue. The removing step comprises ejecting the tissue anchor from the device into the hole. The hole passes completely through the tissue and the delivering step comprises delivering the device through the hole and the removing step comprises placing the tissue anchor on an opposite side of the hole. The method further comprises maintaining the wound closure device in position at the surgical site as the terminal ends of the suture are pulled to form the cluster of the plurality of connected knots at the surgical site.


The details of one or more implementations of the disclosure are set forth in the accompanying drawings and the description below. Other features and advantages will be apparent from the description and drawings, and from the claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A illustrates an implementation of a tissue repair apparatus.



FIG. 1B illustrates another implementation of a tissue repair apparatus.



FIG. 1C illustrates an implementation of a tissue repair apparatus after sliding of curved portions of a fixation member with respect to a suture to form a cluster or bunch including a number of folds.



FIG. 2 illustrates the tissue repair apparatus of FIG. 1A including an additional suture interwoven through the construct.



FIG. 3 illustrates an alternative implementation of weaving the suture through the fixation member of FIG. 1A.



FIG. 4 illustrates another implementation of a tissue repair apparatus.



FIG. 5 illustrates the tissue repair apparatus of FIG. 4 including an additional suture interwoven through the construct.



FIGS. 6A-6G illustrate implementations of delivery devices used for delivery and placement of the tissue repair apparatuses of FIGS. 1A-5 at a surgical site.





DETAILED DESCRIPTION

Referring to FIG. 1A, a tissue repair apparatus 100 includes a fixation member or anchor 10 and a flexible member or suture 20 interwoven through the fixation member 10. The fixation member 10 is formed of a malleable or flexible braided body 12 having a longitudinal extent extending between a first end 12a and a second end 12b and a width W. The body 12 defines a plurality of openings 14 formed crosswise through, or substantially along, the width W of the body 12. The suture 20 includes two terminal ends, 20a and 20b. One of the terminal ends 20a, 20b is passed through each of the openings 14 in the body 12 forming multiple curved portions 30 of the fixation member 10 and two substantially parallel sections 22, 24 of the suture 20. As shown in FIG. 1A, the curved portions 30 pass from one section 22, 24 to the other of the sections 22, 24 along the length of the fixation member 10 to form substantially S-shaped curved portions 30. The curved portions 30 may slide with respect to the suture 20 to form a cluster or bunch 30 including a number of folds as shown in FIG. 1C. The cluster 30, in conjunction with the terminal ends 20a, 20b, may be used to secure tissue within a surgical site as will be described in more detail below.


In the implementation shown in FIG. 1A, the fixation member 10 and the suture 20 are made from size 2 non-tubular braided sutures. However, the fixation member 10 may be a tape, mesh, tube, or other type of malleable or flexible structure, and the suture 20 may be made from a suture of different size depending upon the surgical procedure or application. For example, in another exemplary implementation, the fixation member 10 and/or the suture 20 are made from a flattened tubular suture. In addition, while the fixation member 10 of FIG. 1A includes at least four curved portions 30, other configurations are possible, such as the implementation shown in FIG. 1B, where the fixation member 10 has a smaller length dimension and therefore includes three curved portions 30 when the suture 20 is interwoven therethrough. In yet another implementation, the fixation member 10 can include two curved portions 30 and be formed substantially in a S-shaped configuration. Varying the length and width dimensions of the fixation member 10, and/or varying the size of the suture 20, and/or the number of openings through the fixation member 10 through which the suture 20 passes, may affect the size of the cluster 30 formed by the fixation member 10 within the surgical site. These varying configurations may provide the user with flexibility to meet the needs for a number of various surgical procedures.


Referring to FIG. 2, the tissue repair apparatus 100 of FIG. 1A may also include an additional flexible member or suture 40 having two terminal ends 40a, 40b. One of the two ends 40a, 40b may be interwoven around or through the fixation member 20 forming a construct yielding four free ends 20a, 20b, 40a, and 40b. An apparatus with four free ends may have advantages over two free ends in certain implementations. For example, in some applications, such as rotator cuff repair, it is often necessary to tie down the tissue to the bone at two locations in order to secure the tissue to the bone. In these applications, providing four free ends with only one fixation member within the bone reduces the number of fixation members needed, which may lower procedure time and cost. Reducing the number of fixation members may also reduce the risk of stress concentrations due to multiple drilled holes causing a risk of fracture at the repair site post-operatively.


Referring to FIG. 3, an alternative implementation of weaving the suture 20 through the fixation member 10 of FIG. 1A is illustrated. One of the terminal ends 20a, 20b is passed through each of the openings 14 in the body 12 forming multiple curved portions 30 of the fixation member 10 and two substantially parallel sections 22, 24 of the suture 20. Unlike the curved portions 30 formed by the weaving pattern illustrated in FIG. 1A, the curved portions 30 of FIG. 3 do not pass from one tail section 22, 24 to the other of the tail sections 22, 24 along the length of the fixation member 10 to form substantially S-shaped curved portions 30. Instead, in the implementation shown in FIG. 3, curved portions 30 form substantially S-shaped curved portions 30 along the length of the portion of the suture 10 that is interwoven through the fixation member 10. This weaving pattern may allow for a smaller diameter hole to be drilled into bone for receiving the fixation member 10, which may aid in the reduction of stress concentrations and fracture. In addition, the weaving pattern may permit access to surgical sites that are too small or confined for existing tissue anchor assemblies.


Referring to FIG. 4, in another implementation, an apparatus for tissue repair 200 includes a fixation member or anchor 210 and the flexible member or suture 20 interwoven through the fixation member 210. The fixation member 210 may be formed as a sequence of connected knots 215. In the particular implementation shown in FIG. 4, the sequence of knots 215 includes a square knot 220, two free alternating post half hitch knots 222, 224, a square knot 226, two free alternating post half hitch knots 228, 230, and a square knot 232. The suture 20 may pass through each of the square knots 220, 226, and 232, or any combination of one or more openings formed by the connected knots 215 that permits the fixation member 210 to slide relative to the suture 20 so that the fixation member 210 may form a cluster or bunch within the surgical site and cooperate with the suture 20 to secure tissue within the surgical site as will be described in more detail below. The fixation member 210 and the suture 20 are made from size 2 braided sutures, however, other suture sizes may be employed or tailored for, for example, drill size and strength requirements.


Referring to FIG. 5, the tissue repair apparatus 200 of FIG. 4 may also include an additional flexible member or suture 40 having two terminal ends 40a, 40b. One of the two ends 40a, 40b may be interwoven around or through the fixation member 210, and more particularly, through one or more openings formed by the sequence of knots 215, forming a construct yielding four free ends 20a, 20b, 40a, and 40b. As discussed above, an apparatus with four free ends may have advantages over two free ends in various implementations.



FIGS. 6A-6E represent a tool or delivery device 300 used to deliver any one of the fixation members 10, 210 described with respect to FIGS. 1A, 1B, and 2-3 to a surgical site for repairing, as an example, soft tissue 314. Referring to FIG. 6A, the delivery device 300 includes an inserter tube or cannula 302. One of the fixation members 10, 210 is loaded into the tube or cannula 302 as shown by the arrow in FIG. 6A such that the free ends 20a, 20b of the suture 20 extend through a proximal end 302a of the inserter tube 302 such that the free ends 20a, 20b may be manipulated by a physician. As shown in FIG. 6B, a drill guide 304 is placed within the surgical site 400 and a drill (not shown) is placed within the drill guide 304 and is used to drill a hole 306 of sufficient depth through the cortical layer 310 and into the cancellous bone tissue 312. Alternatively, the drill may be used to drill completely through the cancellous bone tissue 312 in the case of transosseous repair applications. Once the hole 306 is formed in the surgical site 400, the inserter tube 302 containing the loaded fixation member 10, 210 is inserted through the drill guide 304 and into a desired position at the surgical site 400, for example, the inserter tube 302 is tapped into the cortical layer 310.


Referring to FIG. 6C, the inserter tube 302 may then be moved or tapped further into the hole 306 with the fixation member 10, 210 remaining in position within the inserter tube 302. Once the tube 302 is in the desired position within the hole 306, the user may then draw the inserter tube 302 back leaving the fixation member 10, 210 within the hole 306 in the bone (FIG. 6D), or alternatively, on an opposite side of the bone in a transosseous application.


Referring to FIG. 6E, with the fixation member 10, 210 positioned within the hole 306 and a distal end 302b of the inserter tube 302 positioned at the surgical site 400, for example, at or below the cortical layer 310, the user may then pull on one or both of the free ends 20a, 20b of the suture 20. Pulling one or both of the free ends 20a, 20b (and/or the free ends 40a, 40b in those implementations employing two sutures, such as sutures 20, 40 shown in FIG. 2) causes the fixation member 10, 210 to seat against the distal end 302b of the inserter tube 302. As the user continues to pull one or both of the free ends 20a, 20b, the fixation member 10, 210 slides relative to the suture 20, and more particularly, the curved portions 30 of the fixation member 10, or the sequence of knots 215 of the fixation member 210, slide relative to the suture 20 to come together to form a bunch or cluster 30 within the hole 306, for example, at or below the cortical layer 310. With the fixation member 10, 210 in the desired position, the user may then remove the inserter tube 302 and drill guide 304 from the surgical site 400 and tie the free ends 20a, 20b (and/or the free ends 40a, 40b) to secure the tissue 314 to the bone 312.


Maintaining the inserter tube 302 in place throughout insertion and deployment of the fixation member 10, 210 into the surgical site 400 may provide the user with tactile feedback that the fixation member 10, 210 is seated against the inserter tube 302. This may be advantageous over procedures that rely instead on the cortical layer 310 to provide a hard-stop against deployment of the fixation member 10, 210 within the surgical site 400. In those systems, the user feels a fixation member seat or deploy once it contacts the cortical layer 310, which is of various densities across patients. Therefore, the cortical layer 310 in some patients may feel like a hard stop, and in some patients may feel like a soft stop. Thus, there is an increased risk of pulling the fixation member out when trying to deploy or seat the fixation member when relying on the cortical layer to provide a stop to fixation member deployment. In contrast, in the present implementation, the user is provided with a tactile feedback through the inserter tube 302 that the fixation member 10, 210 has deployed and has formed the requisite bunch or cluster within the surgical site 400. This helps reduce the risk of pulling the fixation member 10, 210 out when deploying and seating the fixation member 10, 210.


A number of implementations of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. For example, the fixation members and the flexible members may include a growth factor, such as, for example, an angiogenic factor. The fixation members and the flexible members may also be loaded with a bioactive material, a stimulant, or any substance that promotes healing of the tissue. In addition, while the openings formed in the body of the fixation member are described as being formed substantially crosswise through the body, they may be formed in other orientations depending on the particular application. Moreover, the openings may be formed in the body of the fixation member prior to passing the flexible member through the openings, or the opening may be formed by passing the flexible member through the body of the fixation member, such as, for example, by passing a needle loaded with the flexible member through the body of the fixation member to form a desired number of openings in the fixation member.


In addition, although the process has been described for applications where the fixation member is secured within a hole drilled into bone, the fixation members may also be used in transosseous applications where the depth of the hole is not a constraint. In these applications, the fixation member may be passed entirely through the hole and secured on the backside of the bone. In an alternative implementation (FIG. 6F), the inserter tube 302 may be maintained on top of the cortical layer 310 throughout insertion of the fixation member 10, 210 into the hole 306. In such an implementation, the delivery device 300 includes a slide member 320 disposed within the inserter tube 302 and coupled to the fixation member 10, 210. The user may move the slide member 320 forward within the inserter tube 302 to deploy the fixation member 10, 210 from the inserter tube 302 and into the hole 306. In yet another alternative implementation (FIG. 6G), the delivery device 300 may include a tube 330 placed through the drill guide 304. The tube 330 is tapped into the cortical layer 310 and then receives the inserter tube 302 therethrough. In addition, although the delivery device 300, including the inserter tube 302, has been shown with a straight configuration, the delivery device 300, including the inserter tube 302, may have a curved shape or other suitable configuration depending on the particular surgical location and procedure to be performed.


Moreover, in addition to the particular knot sequence described with respect to the fixation member 210 of FIG. 4, it should be understood that various knot sequences and sizes, and suture sizes, may be used depending on the particular application. Accordingly, other implementations are within the scope of the following claims.

Claims
  • 1. An apparatus for insertion into a bone hole comprising: a flexible fixation member comprising a body formed by two legs and a distal, U-shaped bend joining the two legs, each of the legs terminating in a proximal free end; anda suture received through each of the legs of the flexible fixation member, the suture formed by two legs and a distal, U-shaped bend joining the two legs of the suture, each of the suture legs having a proximal end region, one of the proximal end regions extending from an opening in one of the legs of the body and the other of the proximal end regions extending from an opening in the other of the legs of the body with each proximal end region terminally exiting from the fixation member at the respective opening, the ti-shaped bend of the suture being distal to the U-shaped bend of the body;wherein the fixation member having the U-shaped bend is slidably coupled to the suture and configurable to form a cluster within a surgical site; andwherein the suture extends longitudinally down one leg of the fixation member and longitudinally up the other leg of the fixation member in a single direction without intersecting itself.
  • 2. The apparatus of claim 1, wherein the fixation member comprises suture, tape, braid or mesh.
  • 3. The apparatus of claim 1, wherein the suture only extends a single time through the openings.
  • 4. The apparatus of claim 1, wherein the cluster is defined by a group of folds.
  • 5. The apparatus of claim 1, wherein the opening in the one of the legs is spaced from a terminus of the proximal free end of the one of the legs, and the opening in the other of the legs is spaced from a terminus of the proximal free end of the other of the legs.
  • 6. The apparatus of claim 1, wherein the suture comprises a size 2 suture.
  • 7. The apparatus of claim 1, further comprising a delivery device comprising a cannula configured to receive the fixation member therein.
  • 8. The apparatus of claim 1, wherein an entirety of the suture, including each of the proximal end regions, is slidable with respect to an entire longitudinal extent of the fixation member in either direction.
  • 9. The apparatus of claim 1, wherein a width of the fixation member is uniform along an entire length of the fixation member.
CROSS-REFERENCE TO RELATED APPLICATION(S)

This application is a continuation of U.S. patent application Ser. No. 16/819,243, filed Mar. 16, 2020, entitled TISSUE REPAIR, which is a continuation of U.S. patent application Ser. No. 16/409,944, filed on May 13, 2019, now U.S. Pat. No. 10,588,617, issued Mar. 27, 2020, which is a continuation of U.S. patent application Ser. No. 15/095,225, filed on Apr. 11, 2016, now U.S. Pat. No. 10,631,844, issued Apr. 28, 2020, which is a continuation of U.S. patent application Ser. No. 14/693,322, filed on Apr. 22, 2015, now U.S. Pat. No. 9,370,352, issued Jun. 21, 2016, which is a continuation of U.S. patent application Ser. No. 14/304,269, filed Jun. 13, 2014, now U.S. Pat. No. 9,078,651, issued Jul. 14, 2015, which is a divisional of U.S. patent application Ser. No. 13/016,389, filed on Jan. 28, 2011, now U.S. Pat. No. 8,795,334, issued Aug. 5, 2014. The entire contents of the prior applications are hereby incorporated herein by reference for all purposes.

US Referenced Citations (167)
Number Name Date Kind
2065659 Cullen Dec 1936 A
3580256 Wilkinson May 1971 A
4269246 Larson et al. May 1981 A
4605414 Czajka Aug 1986 A
5217470 Weston Jun 1993 A
5234445 Walker et al. Aug 1993 A
5306301 Graf et al. Apr 1994 A
5405352 Weston Apr 1995 A
5431651 Goble Jul 1995 A
5449367 Kadry Sep 1995 A
5451203 Lamb Sep 1995 A
5484440 Allard Jan 1996 A
5527341 Gogolewski et al. Jun 1996 A
5645588 Graf et al. Jul 1997 A
5690649 Li Nov 1997 A
5718717 Bonutti Feb 1998 A
5769894 Ferragamo Jun 1998 A
5893592 Schulze et al. Apr 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5989252 Fumex Nov 1999 A
5993459 Larsen et al. Nov 1999 A
6033405 Winslow et al. Mar 2000 A
6143029 Rippstein Nov 2000 A
6193754 Seedhom Feb 2001 B1
6296659 Foerster Oct 2001 B1
6436100 Berger Aug 2002 B1
6517578 Hein Feb 2003 B2
7048754 Martin May 2006 B2
7390329 Westra Jun 2008 B2
7390332 Selvitelli et al. Jun 2008 B2
7601165 Stone Oct 2009 B2
7658751 Stone et al. Feb 2010 B2
7731732 Ken Jun 2010 B2
7736378 Maahs et al. Jun 2010 B2
7749250 Stone et al. Jul 2010 B2
7771455 Ken Aug 2010 B2
7780701 Meridew et al. Aug 2010 B1
7905903 Stone et al. Mar 2011 B2
7905904 Stone et al. Mar 2011 B2
7909851 Stone et al. Mar 2011 B2
7959650 Kaiser et al. Jun 2011 B2
7972292 Behl et al. Jul 2011 B2
8057511 Flores et al. Nov 2011 B2
8088130 Kaiser et al. Jan 2012 B2
8118836 Denham et al. Feb 2012 B2
8128640 Harris et al. Mar 2012 B2
8128658 Kaiser et al. Mar 2012 B2
8137382 Denham et al. Mar 2012 B2
8172871 Ken May 2012 B2
8241305 Stone Aug 2012 B2
8298262 Stone et al. Oct 2012 B2
8303604 Stone et al. Nov 2012 B2
8308765 Saadat et al. Nov 2012 B2
8361113 Stone et al. Jan 2013 B2
8409253 Stone et al. Apr 2013 B2
8795334 Astorino Aug 2014 B2
8986327 Karasic et al. Mar 2015 B2
9078651 Astorino Jul 2015 B2
9173645 Overes et al. Nov 2015 B2
9307977 McDevitt et al. Apr 2016 B2
9370352 Astorino Jun 2016 B2
9421008 Burkhart et al. Aug 2016 B2
9826971 Lombardo et al. Nov 2017 B2
9962149 Brown et al. May 2018 B2
10010314 Karasic et al. Jul 2018 B2
10292697 Karasic et al. May 2019 B2
10588617 Astorino Mar 2020 B2
10617408 Karasic et al. Apr 2020 B2
10631844 Astorino Apr 2020 B2
11413031 Astorino Aug 2022 B2
11607211 Karasic et al. Mar 2023 B2
20010002440 Bonutti May 2001 A1
20010041938 Hein Nov 2001 A1
20020029066 Foerster Mar 2002 A1
20020115999 McDevitt et al. Aug 2002 A1
20030050666 Grafton Mar 2003 A1
20030130694 Bojarski et al. Jul 2003 A1
20030149448 Foerster et al. Aug 2003 A1
20040133238 Cerier Jul 2004 A1
20040181234 McDevitt et al. Sep 2004 A1
20040220573 McDevitt et al. Nov 2004 A1
20040225292 Sasso et al. Nov 2004 A1
20050033364 Gregoire et al. Feb 2005 A1
20050149118 Koyfman et al. Jul 2005 A1
20050187577 Selvitelli et al. Aug 2005 A1
20050209622 Carrison Sep 2005 A1
20050251159 Ewers et al. Nov 2005 A1
20050277985 Wert et al. Dec 2005 A1
20060155328 Foerster Jul 2006 A1
20060178680 Nelson et al. Aug 2006 A1
20060229671 Steiner et al. Oct 2006 A1
20060259076 Burkhart et al. Nov 2006 A1
20060293709 Bojarski et al. Dec 2006 A1
20070010857 Sugimoto et al. Jan 2007 A1
20070016244 Behl et al. Jan 2007 A1
20070156174 Kaiser et al. Jul 2007 A1
20070185532 Stone Aug 2007 A1
20070239209 Fallman Oct 2007 A1
20080065070 Fried et al. Mar 2008 A1
20080065114 Stone et al. Mar 2008 A1
20080140092 Stone et al. Jun 2008 A1
20080140093 Stone et al. Jun 2008 A1
20080188893 Selvitelli et al. Aug 2008 A1
20080208204 Schmieding et al. Aug 2008 A1
20080208252 Holmes Aug 2008 A1
20080255557 Koyfman et al. Oct 2008 A1
20080255613 Kaiser et al. Oct 2008 A1
20080312689 Denham et al. Dec 2008 A1
20090036905 Schmieding Feb 2009 A1
20090062846 Ken Mar 2009 A1
20090062847 Ken Mar 2009 A1
20090069823 Foerster et al. Mar 2009 A1
20090082805 Kaiser et al. Mar 2009 A1
20090187194 Hamada Jul 2009 A1
20090240335 Arcenio et al. Sep 2009 A1
20090248068 Lombardo et al. Oct 2009 A1
20090259260 Bentley et al. Oct 2009 A1
20090306711 Stone et al. Dec 2009 A1
20090312776 Kaiser et al. Dec 2009 A1
20090318961 Stone et al. Dec 2009 A1
20090326545 Schaffhausen Dec 2009 A1
20100023056 Johansson et al. Jan 2010 A1
20100114163 Martin May 2010 A1
20100130989 Bourque et al. May 2010 A1
20100145384 Stone et al. Jun 2010 A1
20100211075 Stone Aug 2010 A1
20100249809 Singhatat et al. Sep 2010 A1
20100256677 Albertorio et al. Oct 2010 A1
20100268273 Albertorio et al. Oct 2010 A1
20100268275 Stone et al. Oct 2010 A1
20110009867 Oren et al. Jan 2011 A1
20110022061 Orphanos et al. Jan 2011 A1
20110022083 DiMatteo Jan 2011 A1
20110022084 Sengun et al. Jan 2011 A1
20110077667 Singhatat et al. Mar 2011 A1
20110098727 Kaiser et al. Apr 2011 A1
20110098728 McDevitt et al. Apr 2011 A1
20110152885 McDevitt et al. Jun 2011 A1
20110152929 McDevitt et al. Jun 2011 A1
20110238111 Frank Sep 2011 A1
20110264141 Denham et al. Oct 2011 A1
20110270278 Overes et al. Nov 2011 A1
20120046693 Denham et al. Feb 2012 A1
20120053630 Denham et al. Mar 2012 A1
20120059417 Norton et al. Mar 2012 A1
20120116450 McDevitt et al. May 2012 A1
20120130422 Hootstein May 2012 A1
20120150297 Denham et al. Jun 2012 A1
20120197271 Astorino et al. Aug 2012 A1
20120215257 McDevitt et al. Aug 2012 A1
20120239085 Schlotterback Sep 2012 A1
20120290004 Lombardo et al. Nov 2012 A1
20130018416 Lombardo et al. Jan 2013 A1
20130023930 Stone et al. Jan 2013 A1
20130035722 McDevitt et al. Feb 2013 A1
20130110165 Burkhart et al. May 2013 A1
20130123810 Brown et al. May 2013 A1
20130123813 Stone et al. May 2013 A1
20130138123 Stone et al. May 2013 A1
20130158601 Stone et al. Jun 2013 A1
20130178901 Arai et al. Jul 2013 A1
20130237997 Arai et al. Sep 2013 A1
20130296934 Sengun Nov 2013 A1
20130345748 Dreyfuss Dec 2013 A1
20140052178 Dooney, Jr. Feb 2014 A1
20140052179 Dreyfuss et al. Feb 2014 A1
20140114330 Karasic et al. Apr 2014 A1
Foreign Referenced Citations (31)
Number Date Country
101252887 Aug 2008 CN
101888810 Nov 2010 CN
0328401 Aug 1989 EP
0684013 Nov 1995 EP
1917915 May 2008 EP
2277456 Jan 2011 EP
2606833 Jun 2013 EP
2749230 Feb 2014 EP
2743294 Jul 1997 FR
2370227 Jun 2002 GB
H08-052155 Feb 1996 JP
2006-503655 Feb 2006 JP
2010-500912 Jan 2010 JP
2010-537746 Dec 2010 JP
2011-025036 Feb 2011 JP
2003092551 Nov 2003 WO
2004037094 May 2004 WO
2006023793 Mar 2006 WO
2006086275 Aug 2006 WO
2007005394 Jan 2007 WO
2007037326 Apr 2007 WO
2008022250 Feb 2008 WO
2008137197 Nov 2008 WO
2009029914 Mar 2009 WO
2009052294 Apr 2009 WO
2011058340 May 2011 WO
2012048050 Apr 2012 WO
2012103536 Aug 2012 WO
2012112793 Aug 2012 WO
2013134277 Sep 2013 WO
2014062684 Apr 2014 WO
Non-Patent Literature Citations (38)
Entry
“Technique for AGL reconstruction with Acufex Director Drill Guide and Endobutton CL” © 1999, Smith & Nephew, Inc., 20 pages.
“Endobutton Direct: Fixation Device,” Smith & Nephew, Inc., reprinted from http://global.smith-nephew.com/us/ product23376_5895.htm, on Nov. 22, 2010, 3 pages.
“Endobutton CL,” Smith and Nephew, Inc., reprinted from http://endo.smith-nephew.com/es/Standard.asp? NodeID=2715, on Nov. 22, 2010, 1 page.
“ToggleLOC: Femoral Fixation Device with Zip Loop Technology,” Biomet Sports Medicine. Inc., 2007, 8 pages.
Scope This Out, vol. 10, No. 2, Summer 2008, 8 pages.
Scope This Out, vol. 12, No. 2, Fall 2010, 8 pages.
Scope this Out, vol. 12, No. 1, Spring 2010, 8 pages.
“Shoulder Restoration System: Y-Knot™ 1.3mm All-Suture Anchor,” ConMed™ Linvatec, 2011, 4 pages.
“Shoulder Restoration System: Arthroscopic Bankart Repair Using the Y-Knot™ 1.3mm All-Suture Anchor,” ConMed™ Linvatec, 2011, 4 pages.
“Game Plan: Innovative Products to be Launched AAOS 2010,” Biomet Sports Medicine, Spring 2010, vol. 2, No. 3, 1 page.
From, Stuart, “ACL Reconstruction with Bone-Tendon-Bone Transplants using the Endobutton CL BTB Fixation System,” Smith & Nephew, Inc., © 2004, printed on Apr. 4, 11 pages.
Glousman, R., et al., “JuggerKnot Soft Anchor Surgical Technique,” Biomet Sports Medicine, 2010, 1 page.
Lawhorn, K., “MaxFire MarXmen Device Surgical Technique,” Biomet Sports Medicine, 2010, 1 page.
Examination Report in AU Application No. AU2013230095 dated Nov. 2, 2016.
Exmination Report in AU Application No. 2012211072 dated Aug. 12, 2015.
Office Action in CN Application No. 201380066543.7 dated Sep. 27, 2016.
First Office Action CN201380013146.3 dated Apr. 14, 2016 (w/English trans.).
Office Action in CN Application No. 201380013146.3 dated Dec. 26, 2016.
Office Action in CN Application No. 201280006593.1 dated Sep. 2, 2015.
Search Report in CN Application No. 201380066543.7 dated Dec. 29, 2017.
Communication in EP Application No. 13786021.9 dated Dec. 13, 2016.
Office Action EP Application No. 13712402.0 dated Nov. 4, 2016.
Search Report in EP Application No. 2018555.9 dated Nov. 9, 2020.
Examination Report in EP Application No. 12702737.3 dated Nov. 19, 2019.
Office Action EP Application No. 12702737.3 dated Feb. 21, 2017.
Communication under Article 94(3) in EP Application No. 12702737.3 dated Feb. 24, 2016.
Examination Report in IN Application No. 6029/DELNP/2013 dated Oct. 12, 2019.
International Search Report and Written Opinion in Application No. PCT/US2012/023056, dated Jun. 13, 2012.
International Search Report in Application No. PCT/US2013/029143, dated Jun. 13, 2013.
International Search Report in Application No. PCT/US2013/065064, dated Feb. 21, 2014.
Office Action in JP Application No. 2014-561043 dated Jan. 16, 2017.
Decision of Rejection in JP Application No. 2013-551405 dated Jul. 25, 2016.
Notice of Reasons for Rejection JP Application No. 2016-228862 dated Oct. 18, 2019.
Pre-Appeal Report, Examiner's Comments in JP Application No. 2016-228862 dated Nov. 29, 2018.
Decision to Reject the Amendments in JP Application No. 2016-228862 dated Apr. 11, 2018.
Communication of the Substantive Examination Report for MX Application No. MX/a/2013/008734 dated Jul. 27, 2015.
Office Action from RU Application No. 2014136769/14(059452) dated Dec. 30, 2017.
Inquiry made in Course of Substantive Examination of RU Application No. 2013138875/14(058293) dated Nov. 18, 2015.
Related Publications (1)
Number Date Country
20220313242 A1 Oct 2022 US
Divisions (1)
Number Date Country
Parent 13016389 Jan 2011 US
Child 14304269 US
Continuations (5)
Number Date Country
Parent 16819243 Mar 2020 US
Child 17846093 US
Parent 16409944 May 2019 US
Child 16819243 US
Parent 15095225 Apr 2016 US
Child 16409944 US
Parent 14693322 Apr 2015 US
Child 15095225 US
Parent 14304269 Jun 2014 US
Child 14693322 US